Expression of PD-L1 and BCG immunotherapy in non-muscle invasive bladder cancer

被引：2
|
作者：
Heo, Jun Hyeok
Jin, Hyun A.
Kang, You Hyun
Kim, Ki Hong
Hong, Sung Joon
Han, Kyung Seok
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.TME16-A16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A16
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC)
    Alvarez-Maestro, M.
    Guerrero-Ramos, F.
    Rodriguez-Faba, O.
    Dominguez-Escrig, J. L.
    Fernandez-Gomez, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (02): : 93 - 102
  • [42] Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non-Muscle Invasive Bladder Cancer
    Yamashita, Takahisa
    Higashi, Morihiro
    Yamazaki, Mami
    Imada, Hiroki
    Takayanagi, Natsuko
    Shimizu, Tomomi
    Sawada, Keisuke
    Yamamoto, Wataru
    Murakami, Chiaki
    Nagata, Marino
    Kikuchi, Yukina
    Momose, Shuji
    PATHOLOGY INTERNATIONAL, 2025,
  • [43] Expression of RPL9 predicts the recurrence of non-muscle invasive bladder cancer with BCG therapy
    Piao, Xuan-Mei
    Kim, Yeong Uk
    Byun, Young Joon
    Zheng, Chuang-Ming
    Moon, Sung Min
    Kim, Kyeong
    Lee, Hee Youn
    Jeong, Pildu
    Kang, Ho Won
    Kim, Won Tae
    Lee, Sang-Cheol
    Kim, Wun-Jae
    Yun, Seok Joong
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 197.e1 - 197.e9
  • [44] Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy
    Ahmet Murat Aydin
    Dilek E. Baydar
    Berk Hazir
    Berrin Babaoglu
    Cenk Y. Bilen
    World Journal of Urology, 2020, 38 : 2537 - 2545
  • [45] Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy
    Aydin, Ahmet Murat
    Baydar, Dilek E.
    Hazir, Berk
    Babaoglu, Berrin
    Bilen, Cenk Y.
    WORLD JOURNAL OF UROLOGY, 2020, 38 (10) : 2537 - 2545
  • [46] Therapeutic Advances in Bladder Preservation for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
    Lange, Alyssa
    Madiraju, Srigita
    Petros, Firas G.
    CANCERS, 2025, 17 (04)
  • [47] THE BLADDER TUMOR MICROBIOME MAY AUGMENT RESPONSE TO BCG IN NON-MUSCLE INVASIVE BLADDER CANCER
    Lone, Zaeem
    Knorr, Jacob
    Werneburg, Glenn
    Adler, Ava
    Agudelo, Jose
    Campbell, Rebecca
    Bajic, Petar
    Almassi, Nima
    Weight, Christopher
    Pascal-Haber, Georges
    Miller, Aaron
    Lee, Byron
    JOURNAL OF UROLOGY, 2023, 209 : E732 - E732
  • [48] BLADDER TUMOR MICROBIOME MAY AUGMENT RESPONSE TO BCG IN NON-MUSCLE INVASIVE BLADDER CANCER
    Knorr, Jacob
    Werneburg, Glenn
    Adler, Ava
    Agudelo, Jose
    Murthy, Prithvi
    Campbell, Rebecca
    Bajic, Petar
    Almassi, Nima
    Weight, Christopher
    Haber, Georges-Pascal
    Miller, Aaron
    Lee, Byron
    JOURNAL OF UROLOGY, 2022, 207 (05): : E195 - E195
  • [49] Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis
    Kubon, Jennifer
    Sikic, Danijel
    Eckstein, Markus
    Weyerer, Veronika
    Stohr, Robert
    Neumann, Angela
    Keck, Bastian
    Wullich, Bernd
    Hartmann, Arndt
    Wirtz, Ralph M.
    Taubert, Helge
    Wach, Sven
    CANCERS, 2020, 12 (10) : 1 - 13
  • [50] Correlation between BMI, Diabetes Mellitus, and Outcomes in Patients Treated with BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer
    Brooks, N. A.
    Matulay, J. T.
    Li, R.
    Kokorovic, A.
    Grossman, H. B.
    Shen, Y.
    Gao, J. J.
    Navai, N.
    Dinney, C. P. N.
    Kamat, A. M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 902 - 903
12345